FDA Approves Oral Semaglutide as the First Oral GLP 1 Pill Revance and TEOXANE Labs Get FDA Approval for RHA Dynamic Volume Revance posted on the topic LinkedIn FDA Approves Loargys for Arginase 1 Deficiency Treatment flok Health posted on the topic LinkedIn FDA Peptide Reclassification 2026 Amanecia Health Not all peptides are restricted. Here's the breakdown you actually need. The FDA's Category 2 classification affects specific compounded peptides BPC 157, TB 500, CJC 1295 Ipamorelin, AOD 9604, Epithalon, Selank, Semax. Others like Sermorelin The FDA's Decision to Ban Compounds: What You Need to Know